Kiran — 38/M, Non-Alcoholic Recurrent Acute Pancreatitis (2 Episodes), Normal Lipids, Suspected Genetic Cause

1. Genetic Work-Up: What to Suspect and Test

Only PRSS1 mutations are sufficient to precipitate pancreatitis in the absence of other risk factors. All others are disease modifiers or require co-triggers. — Harrison's Principles of Internal Medicine 22E, p. 2788

Genetic testing for PRSS1, SPINK1, CFTR, CTRC, and others is commercially available. — Sleisenger and Fordtran's GI & Liver Disease

2. Long-Term Dietary Management

Core Principle: Low-Fat Diet

• Fat: ≤30–40 g/day (20–25% of total calories from fat) — fat is the principal stimulus for CCK-mediated pancreatic exocrine secretion
• Prefer unsaturated fats (olive oil, nuts in small amounts) over saturated/trans fats
• Avoid frying, cream, butter, full-fat dairy, fatty meats

Macronutrient Targets

Foods to Encourage

• Soft, low-fat cooked foods (steamed, boiled, baked)
• Fresh fruits and vegetables
• Lean proteins: chicken breast, fish, tofu, lentils
• Small, frequent meals (5–6 meals/day rather than 2–3 large ones)
• Adequate hydration (2–2.5 L water/day)

Foods to Strictly Avoid

• Alcohol (even small amounts — a direct pancreatic toxin; triggers attacks even in genetic disease) — Yamada's Textbook of Gastroenterology 7E
• Fried and fatty foods (deep-fried snacks, samosas, chips)
• Red meat in excess; processed meats
• Heavy spices in large quantities
• Concentrated sweets, sugar-sweetened beverages
• Eating to satiety in a single meal (large meal = strong CCK stimulus)

Micronutrients

3. Acute Episode Management (When Attacks Occur)

4. Prevention of Recurrence — Long-Term Strategy

Mandatory Lifestyle Modifications

1. Absolute alcohol abstinence — even in genetic pancreatitis, alcohol acts as an environmental co-trigger
2. Smoking cessation — smoking independently doubles the risk of recurrent pancreatitis and accelerates progression to chronic pancreatitis (Yamada's Gastroenterology 7E, Prevention section)
3. Maintain normal BMI — obesity worsens severity

Surveillance and Monitoring

• Annual serum glucose / HbA1c — pancreatogenic (type 3c) diabetes risk with recurrent attacks
• Fecal elastase-1 every 1–2 years — to detect exocrine pancreatic insufficiency (EPI) early
• MRCP/EUS every 1–2 years — monitor for ductal changes, stones, early chronic pancreatitis
• Pancreatic cancer screening — hereditary pancreatitis carries significantly elevated lifetime risk of pancreatic adenocarcinoma; EUS/MRCP surveillance from age 40 or 20 years after first attack (as per guidelines for high-risk individuals)
• Serum calcium (r/o hyperparathyroidism as co-trigger), serum IgG4

If Genetic Mutation Confirmed (e.g., PRSS1)

• Refer to a specialist genetic counseling service
• Screen first-degree relatives
• Discuss TOTAL PANCREATECTOMY WITH ISLET AUTOTRANSPLANTATION (TPIAT) — considered for patients with disabling recurrent attacks progressing toward chronic pancreatitis despite maximal medical therapy; preserves endocrine function
• Avoid pancreatotoxic medications (valproate, azathioprine, tetracyclines, thiazides — document clearly in records)

Pain Management Between Episodes

• Non-opioid analgesics first (paracetamol, NSAIDs per renal status)
• Adjuvants: gabapentin/pregabalin for neuropathic pain component
• Avoid long-term opioid use
• Pancreatic enzyme supplementation (PERT) can reduce pain by reducing CCK stimulation even before frank EPI develops

5. Summary Care Plan for Kiran

SHORT-TERM
□ Genetic panel: PRSS1, SPINK1, CFTR, CTRC, CPA1
□ MRCP to exclude pancreas divisum, ductal anomaly, stones
□ Serum IgG4, calcium, PTH
□ Fasting glucose, HbA1c, fecal elastase-1

DIET (start immediately)
□ Low-fat diet ≤40 g fat/day
□ 5–6 small meals/day
□ Absolute alcohol abstinence
□ Smoking cessation support if applicable

MONITORING
□ Annual HbA1c, fecal elastase
□ MRCP every 1–2 years
□ EUS/pancreatic cancer surveillance from age 40

IF GENETIC MUTATION FOUND
□ Genetic counseling + family screening
□ Consider TPIAT referral if progressing to chronic disease
□ Avoid pancreatotoxic drugs — document in EMR

• Harrison's Principles of Internal Medicine 22E (2025), p. 2788 — genetic factors and management
• Sleisenger & Fordtran's GI and Liver Disease — nutrition in acute pancreatitis, genetic section
• Current Surgical Therapy 14e — nutrition guidelines (early feeding, low-fat diet)
• Yamada's Textbook of Gastroenterology 7E — prevention, genetic classification (Whitcomb 2019 framework)
• Tietz Textbook of Laboratory Medicine 7E — hereditary pancreatitis genetics